and 129.57 (Ar-CH) and 138.21, 138.61, 138.75 and 138.91
(Ar-C quaternary); m/z (CI) 553 (44%, [M ϩ H]ϩ), 463 (100,
[MH2 Ϫ C7H7]ϩ), 373 (64, [MH3 Ϫ 2 × C7H7]ϩ) and 91 (20,
[C7H7]ϩ).
m, 2 × 4-H of Cha), 1.02–1.15 [8 H, m, 2 × (2 × 2-H and 2 ×
3-H of Cha)], 1.30–1.43 (4 H, m, 2 × 4-H of Cha, 3-H, 5-H),
1.50–1.59 [4 H, m, 2 × (2 × 3-H of Cha)], 1.65–1.76 [5 H, m,
2 × (2 × 2-H of Cha) and 5-H], 1.81–1.89 (1 H, m, 3-H), 2.80
(1 H, dd, 2JH-H 13.5, 3JH-H 7.5, 3Ј-H), 2.92 (1 H, dd, 2JH-H 13.5,
3JH-H 6.0, 3Ј-H), 3.07–3.13 (2 H, m, 2 × 1-H of Cha), 3.46 (1 H,
dd, 2JH-H 11.5, 3JH-H 6.0, 1Ј-H), 3.59–3.65 (1 H, m, 1Ј-H), 3.76–
3.81 (1 H, br s, 2-H), 3.86–3.92 (1 H, m, 2Ј-H), 3.92–4.04 (3 H,
m, 4-H, 2-H and 1-H) and 7.10–7.30 (5 H, m, Ar-H); δC(75.4
MHz; 2H2O) 24.40 and 24.90 (3-C and 4-C of Cha), 30.96 (2-C
of Cha), 34.60 (3-C, broad), 36.82 (5-C), 37.58 (3Ј-C), 51.01
(1-C of Cha), 62.85 (1Ј-C), 66.36 (C tertiary), 66.63 (C tertiary),
(؊)-(1R,2R,4S,6S,2ЈR)-1-(Diphenoxyphosphoryloxy)-2,4-bis-
(benzyloxy)-6-(1Ј-benzyloxy-3Ј-phenylpropan-2-yloxy)cyclo-
hexane 27
This compound was prepared in a manner identical with that
described for the phosphate triester (Ϫ)-(1R,2R,4S,6S,2ЈS)-23,
using alcohol (Ϫ)-26 (450 mg, 0.82 mmol) to give phosphate
triester (Ϫ)-27 as a colourless oil (530 mg, 83%) (HRMS:
found: [M ϩ H]ϩ, 785.3253. C48H50O8P requires 785.3243); [α]D
Ϫ2.1 (c 0.6125 in MeOH); δH(300 MHz; C2HCl3) 1.45–1.61
(2 H, m, 3-H and 5-H), 2.19–2.29 (1 H, m, secondary-H), 2.36–
2.46 (1 H, m, secondary-H), 2.74 (1 H, dd, 2JH-H 13.7, 3JH-H 8.2,
3Ј-H), 2.94 (1 H, dd, 2JH-H 13.7, 3JH-H 5.2, 3Ј-H), 3.35 (1 H, dd,
2JH-H 10.2, 3JH-H 6.0, 1Ј-H), 3.43 (1 H, dd, 2JH-H 10.2, 3JH-H 3.6,
1Ј-H), 3.67–3.78 (1 H, m, 4-H), 3.87–3.96 (1 H, m, 2Ј-H), 3.98–
4.08 (1 H, m, 6-H), 4.04–4.20 (1 H, m, 2-H), 4.33 (1 H, d, 2JH-H
11.8, one of OCH2Ph), 4.39–4.45 (3 H, m, 1.5 of OCH2Ph),
4.48 (2 H, s, OCH2Ph), 4.52–4.60 (1 H, m, 1-H) and 7.2–7.5 (20
H, m, Ar-H); δC(75.4 MHz; C2HCl3) 33.71 (3-C), 35.84 (5-C,
broad), 38.27 (3Ј-C), 70.47 (OCH2Ph), 71.26 (4-C), 71.88
(OCH2Ph), 72.12 (1Ј-C), 73.23 (OCH2Ph), 73.80 (6-C, 3JC-P 6.5),
74.92 (2-C), 79.94 (2Ј-C), 82.59 (1-C, broad), 120.11, 120.19,
120.25, 120.30, 125.27, 126.11, 127.49, 127.52, 127.55, 127.58,
127.6, 128.29, 128.35, 128.39, 129.53, 129.63, 129.71 and 129.76
(Ar-CH), 138.36, 138.43, 138.55 and 138.66 (Ar-C quaternary),
150.73 (Ar-C quaternary, 2JC-P 7.6) and 150.8 (Ar-C quaternary,
2JC-P 2.1); δP(121.5 MHz; C2HCl3) Ϫ12.22; m/z (FAB-MS) 785
(15%, [M ϩ H]ϩ) and 251 (100, [(PhO)2PO2H2]ϩ).
3
75.30 (1-C, broad), 75.37 (6-C, JC-P 5.4), 80.02 (2Ј-C), 127.25,
129.45 and 130.26 (Ar-CH) and 139.29 (Ar-C quaternary);
δP(121.5 MHz; 2H2O) 3.0.
Acknowledgements
The authors thank the BBSRC and EPSRC for grants J29893
and K35792, the Wellcome Trust for grant 040331, the EPSRC
for a studentship for M. W. B. and Dr Mahmoud Akhtar for
scientific support.
References
1 J. Schulz and D. Gani, Tetrahedron Lett., 1997, 38, 111: preliminary
communication.
2 D. Gani, C. P. Downes, I. Batty and J. Bramham, Biochem. Biophys.
Acta, 1993, 1177, 253.
3 B. V. L. Potter and D. Lampe, Angew. Chem., Int. Ed. Engl., 1995,
34, 1933.
4 A. P. Leech, G. R. Baker, J. K. Shute, M. A. Cohen and D. Gani,
Eur. J. Biochem., 1993, 212, 693.
5 R. Bone, J. P. Springer and J. R. Atack, Proc. Natl. Acad. Sci.
USA, 1992, 89, 10031.
(؊)-(1R,2R,4S,6S,2ЈR)-1-[Bis(benzyloxy)phosphoryloxy]-2,4-
bis(benzyloxy)-6-(1Ј-benzyloxy-3Ј-phenylpropan-2-yloxy)cyclo-
hexane 28
6 (a) A. G. Cole and D. Gani, J. Chem. Soc., Chem. Commun., 1994,
1139; (b) A. G. Cole and D. Gani, J. Chem. Soc., Perkin Trans. 1,
1995, 2685; (c) A. G. Cole, J. Wilkie and D. Gani, J. Chem. Soc.,
Perkin Trans. 1, 1995, 2695.
This compound was prepared in a manner identical with that
described for the phosphate triester (Ϫ)-(1R,2R,4S,6S,2ЈS)-24,
using the phosphate triester (Ϫ)-27 (500 mg, 0.64 mmol) to give
phosphate triester (Ϫ)-28 as a colourless oil (322 mg, 62%)
(Found: C, 73.65; H, 7.25. C50H53O8P requires C, 73.9; H,
6.6%); [α]D Ϫ3.5 (c 0.405 in MeOH); δH(300 MHz; C2HCl3)
1.38–1.55 (2 H, m, 3-H and 5-H), 2.13–2.23 (1 H, m, secondary-
H), 2.32–2.42 (1 H, m, secondary-H), 2.78 (1 H, dd, 2JH-H 13.7,
3JH-H 8.0, 3Ј-H), 2.96 (1 H, dd, 2JH-H 13.7, 3JH-H 4.9, 3Ј-H), 3.32
(1 H, dd, 2JH-H 10.2, 3JH-H 5.8, 1Ј-H), 3.40 (1 H, dd, 2JH-H 10.2,
3JH-H 3.6, 1Ј-H), 3.66–3.76 (1 H, m, 4-H), 3.83–3.91 (1 H, m, 2Ј-
H), 3.92–3.42 (1 H, m, 6-H), 4.09–4.15 (1 H, m, 2-H), 4.24–4.32
(1 H, m, 1-H), 4.33 (1 H, d, 2JH-H 11.8, one of OCH2Ph), 4.41–
4.48 (3 H, m, 1.5 of OCH2Ph), 4.53 (1 H, d, 2JH-H 11.5, one of
OCH2Ph), 5.00–5.10 (4 H, m, 2 × POCH2Ph) and 7.10–7.40
(30 H, m, Ar-H); δC(75.4 MHz; C2HCl3) 33.82 (3-C), 35.60
7 J. Wilkie, A. G. Cole and D. Gani, J. Chem. Soc., Perkin Trans. 1,
1995, 2709.
8 J. Wilkie and D. Gani, J. Chem. Soc., Perkin Trans. 2, 1996, 783.
9 (a) S. J. Pollack, J. R. Atack, M. R. Knowles, G. McAllister, C. I.
Ragan, R. Baker, S. R. Fletcher, L. L. Iverson and H. B. Broughton,
Proc. Natl. Acad. Sci. USA, 1994, 91, 5766; (b) R. Bone, L. Frank,
J. P. Springer, S. J. Pollack, S. A. Osborne, J. R. Atack, M. R.
Knowles, G. McAllister, C. I. Ragan, H. B. Broughton, R. Baker
and S. R. Fletcher, Biochemistry, 1994, 33, 9460; (c) R. Bone,
L. Frank, J. P. Springer and J. R. Atack, Biochemistry, 1994, 33,
9468.
10 N. S. Gee, C. I. Ragan, K. J. Watling, S. Aspley, R. G. Jackson, G. G.
Reid, D. Gani and J. Shute, Biochem. J., 1988, 249, 883.
11 (a) R. Baker, P. D. Leeson, N. J. Liverton and J. J. Kulagowski,
J. Chem. Soc., Chem. Commun., 1990, 462; (b) R. Baker, C. Carrick,
P. D. Leeson, I. C. Lennon and N. J. Liverton, J. Chem. Soc., Chem.
Commun., 1991, 298.
12 (a) J. Schulz, J. Wilkie, P. Lightfoot, T. J. Rutherford and D. Gani,
J. Chem. Soc., Chem. Commun., 1995, 2353; (b) J. Schulz and
D. Gani, J. Chem. Soc., Perkin Trans. 1, 1997, 657.
13 J. Schulz, J. Wilkie, M. W. Beaton, D. J. Miller and D. Gani,
Biochem. Soc. Trans., 1998, 26, 315.
14 T. K. M. Shing and V. W.-F. Tai, J. Chem. Soc., Perkin Trans. 1, 1994,
2017.
2
(5-C, broad), 38.21 (3Ј-C), 69.09 (POCH2Ph, JC-P 5.4), 69.23
2
(POCH2Ph, JC-P 5.4), 70.48 (OCH2Ph), 71.42 (4-C), 72.0
(OCH2Ph), 72.11 (1Ј-C), 73.23 (OCH2Ph), 74.34 (6-C, 3JC-P 7.5),
74.85 (2-C), 79.59 (2Ј-C), 81.18 (1-C, broad), 126.12, 127.53,
127.57, 127.63, 127.92, 128.32, 128.36, 128.42, 128.46, 128.50,
128.56, 129.67 and 129.77 (Ar-CH) and 138.32, 138.45 and
138.72 (Ar-C quaternary); δP(121.5 MHz; C2HCl3) Ϫ1.33.
15 C. D. Maycock, M. T. Barros, A. G. Santos and I. S. Godinho,
Tetrahedron Lett., 1992, 33, 4633.
16 J. Clèophax, S. D. Gero, J. Leboul, M. Akhtar, J. E. G. Barnett and
C. J. Pearce, J. Am. Chem. Soc., 1976, 98, 7110.
17 R. Grewe and E. Nolte, Liebigs Ann. Chem., 1952, 575, 1.
18 L. Castellanos, J. Cléophax, C. Colas, S. D. Gero, J. Leoboul,
D. Mercier, A. Olesker, A. Rolland, B. Quiclet-Sire and A.-M.
Sepulchre, Carbohydr. Res., 1980, 82, 283.
(؊)-(1R,2R,4R,6R,2ЈR)-2,4-Dihydroxy-6-(1-hydroxy-3-phenyl-
propan-2-yloxy)cyclohexyl bis(cyclohexylammonium) phosphate
[bis(cyclohexylammonium) salt of 29]
19 A. L. Gemal and J.-L. Luche, J. Am. Chem. Soc., 1981, 103,
5454.
20 (a) M. Taniguchi, H. Fujii, K. Oshima and K. Utimoto,
Tetrahedron, 1995, 51, 679; (b) H.-X. Zhai, P.-S. Lei, J. C. Morris,
K. Mensa-Wilmot and T. Y. Shen, Tetrahedron Lett., 1995, 36, 7403.
21 M. Lalonde and C. H. Chan, Synthesis, 1985, 817.
This compound was prepared in a manner identical with that
described for the phosphate (Ϫ)-(1R,2R,4R,6R,2ЈS)-25, using
the triester (Ϫ)-28 (300 mg, 0.37 mmol) to give phosphate (Ϫ)-
29 as a white solid (124 mg, 60%); mp >200 ЊC (decomp.); [α]D
Ϫ12.4 (c 0.335 in MeOH); δH(500 MHz; 2H2O) 0.87–0.98 (2 H,
J. Chem. Soc., Perkin Trans. 1, 2000, 943–954
953